BR112013024323A2 - peptídeos neuroprotetores - Google Patents
peptídeos neuroprotetoresInfo
- Publication number
- BR112013024323A2 BR112013024323A2 BR112013024323A BR112013024323A BR112013024323A2 BR 112013024323 A2 BR112013024323 A2 BR 112013024323A2 BR 112013024323 A BR112013024323 A BR 112013024323A BR 112013024323 A BR112013024323 A BR 112013024323A BR 112013024323 A2 BR112013024323 A2 BR 112013024323A2
- Authority
- BR
- Brazil
- Prior art keywords
- neuroprotective peptides
- neuroprotective
- peptides
- Prior art date
Links
- 230000000324 neuroprotective effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Psychology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161466966P | 2011-03-24 | 2011-03-24 | |
| PCT/IL2012/050104 WO2012127475A1 (en) | 2011-03-24 | 2012-03-22 | Neuroprotective peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013024323A2 true BR112013024323A2 (pt) | 2017-06-13 |
Family
ID=45999925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013024323A BR112013024323A2 (pt) | 2011-03-24 | 2012-03-22 | peptídeos neuroprotetores |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20140045764A1 (https=) |
| EP (1) | EP2688582B1 (https=) |
| JP (1) | JP5960793B2 (https=) |
| KR (1) | KR20140036164A (https=) |
| CN (1) | CN103648517B (https=) |
| AU (1) | AU2012232642B2 (https=) |
| BR (1) | BR112013024323A2 (https=) |
| CA (1) | CA2830792A1 (https=) |
| EA (1) | EA201391387A1 (https=) |
| MX (1) | MX2013010910A (https=) |
| SG (1) | SG193418A1 (https=) |
| WO (1) | WO2012127475A1 (https=) |
| ZA (1) | ZA201307169B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201220899D0 (en) * | 2012-11-21 | 2013-01-02 | Kit Karlsrusher Inst Fuer Technologie Und Inst Fuer Toxikologie Und Genetik And Amcure Gmbh | CD44v6-derived pegylated peptides |
| KR101901669B1 (ko) * | 2016-01-27 | 2018-09-28 | 경상대학교산학협력단 | 아디포넥틴 수용체 활성화 신규 펩티드를 유효성분으로 포함하는 신경질환의 예방, 개선 또는 치료용 조성물 |
| WO2017170924A1 (ja) * | 2016-03-31 | 2017-10-05 | 千寿製薬株式会社 | 神経保護ペプチド |
| EP3438119A4 (en) | 2016-03-31 | 2020-01-08 | Senju Pharmaceutical Co., Ltd. | NEUROPROTECTIVE PEPTIDE |
| EP3712164A4 (en) | 2017-11-14 | 2021-08-18 | Senju Pharmaceutical Co., Ltd. | PEPTIDE STABILIZED BY PACAP |
| AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
| US20220202905A1 (en) | 2019-05-14 | 2022-06-30 | Senju Pharmaceutical Co., Ltd. | Composition for preventing or treating neurotrophic keratitis which contains pacap peptide or stabilized pacap peptide |
| PL3974027T3 (pl) | 2019-05-14 | 2025-02-24 | Senju Pharmaceutical Co., Ltd. | Stabilizowany peptyd pacap |
| CN112569351B (zh) * | 2020-12-16 | 2021-10-15 | 南通大学 | Cd44抗体在制备治疗帕金森疾病的药物中的应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| ATE159953T1 (de) * | 1993-06-18 | 1997-11-15 | Biotie Therapies Oy | Zusammensetzungen und diagnostische verfahren unter verwendung von monoklonalen antikoerpern gegen cd44v6 |
| WO1995019183A1 (en) * | 1994-01-18 | 1995-07-20 | President And Fellows Of Harvard College | Cd44 expression in smooth muscle cells |
| DE19653607A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Int | Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen |
| AU3448899A (en) * | 1998-01-24 | 1999-08-09 | Bristol-Myers Squibb Company | Artificial proteoglycans |
| EP1647556B1 (en) * | 2004-10-14 | 2010-05-19 | Karlsruher Institut für Technologie | Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors |
| JP2010532989A (ja) * | 2007-07-10 | 2010-10-21 | ニューリム ファーマシューティカルズ （１９９１） リミテッド | 神経変性疾患におけるｃｄ４４スプライスバリアント |
| EP2266593A1 (en) * | 2009-06-24 | 2010-12-29 | Karlsruher Institut für Technologie | Use of CD44v6 in the treatment of ophthalmic diseases |
-
2012
- 2012-03-22 US US14/007,010 patent/US20140045764A1/en not_active Abandoned
- 2012-03-22 BR BR112013024323A patent/BR112013024323A2/pt not_active Application Discontinuation
- 2012-03-22 SG SG2013068499A patent/SG193418A1/en unknown
- 2012-03-22 KR KR1020137027914A patent/KR20140036164A/ko not_active Withdrawn
- 2012-03-22 CA CA2830792A patent/CA2830792A1/en not_active Abandoned
- 2012-03-22 WO PCT/IL2012/050104 patent/WO2012127475A1/en not_active Ceased
- 2012-03-22 EA EA201391387A patent/EA201391387A1/ru unknown
- 2012-03-22 MX MX2013010910A patent/MX2013010910A/es not_active Application Discontinuation
- 2012-03-22 AU AU2012232642A patent/AU2012232642B2/en active Active
- 2012-03-22 CN CN201280014793.1A patent/CN103648517B/zh active Active
- 2012-03-22 EP EP12716661.9A patent/EP2688582B1/en active Active
- 2012-03-22 JP JP2014500540A patent/JP5960793B2/ja active Active
-
2013
- 2013-09-18 ZA ZA2013/07169A patent/ZA201307169B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012232642B2 (en) | 2016-12-08 |
| KR20140036164A (ko) | 2014-03-25 |
| JP2014510101A (ja) | 2014-04-24 |
| AU2012232642A1 (en) | 2013-10-17 |
| CN103648517B (zh) | 2016-04-20 |
| CA2830792A1 (en) | 2012-09-27 |
| ZA201307169B (en) | 2014-05-28 |
| EP2688582B1 (en) | 2017-02-15 |
| CN103648517A (zh) | 2014-03-19 |
| JP5960793B2 (ja) | 2016-08-02 |
| EP2688582A1 (en) | 2014-01-29 |
| WO2012127475A1 (en) | 2012-09-27 |
| US20140045764A1 (en) | 2014-02-13 |
| EA201391387A1 (ru) | 2014-01-30 |
| MX2013010910A (es) | 2014-03-27 |
| SG193418A1 (en) | 2013-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301241I2 (nl) | Belantamab mafodotin | |
| NL301233I2 (nl) | spesolimab | |
| FIC20210028I1 (fi) | Evinakumab | |
| NL301081I2 (nl) | Avelumab | |
| FIC20250006I1 (fi) | Flortausipiiri | |
| BR112014004902A2 (pt) | peptídeos | |
| CO7020866A2 (es) | Péptidos terapéuticos | |
| DK2797616T3 (da) | Celle-penetrerende peptider | |
| DE102011100082A8 (de) | Traygreifvorrichtung | |
| PL2663506T3 (pl) | Zamknięcie | |
| EP2752374A4 (en) | gooseneck | |
| HUE040412T2 (hu) | Fúróimplantátum-sebészethez | |
| BR112014000879A2 (pt) | deflegmador | |
| FI20116212L (fi) | Polypeptidi | |
| EP2723481A4 (en) | FLOW COMPENSATOR | |
| BR112013024323A2 (pt) | peptídeos neuroprotetores | |
| CL2014002180A1 (es) | Peptidos antomicrobianos | |
| EP2785523A4 (en) | MATERIAL REFLECTING HEAT | |
| DK2476953T3 (da) | Fluidbedkedel | |
| BR112013009679A2 (pt) | peptídeo | |
| EP2747907A4 (en) | SINKING PANEL OF ORES | |
| EP2694655A4 (en) | pAVEC | |
| FIC20220010I1 (fi) | Frunevetmabi | |
| FIU20114066U0 (fi) | Radon-putkitusjärjestely | |
| IL228354A0 (en) | Neuroprotective peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |